MedPath

Evaluation study of the need for the diuretics and an antiemetic, in cisplatin containing regimen.

Phase 2
Conditions
Malignancy
Registration Number
JPRN-UMIN000014878
Lead Sponsor
Kansai Medical University Hirakata Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
70
Inclusion Criteria

Not provided

Exclusion Criteria

1)History of administration platinum-based chemotherapy 2)With Serious infectious disease 3)Interstitial pneumonia or pulmonary fibrosis detectable on chest Xp 4) A history or cardiac dysfunction 5)With massive pleural effusion or ascites 6)History of serious disease condition 7)History of drug allergy 8) The hope of pregnancy or cases that may pregnant women, pregnant woman 9) Cases of breast-feeding 10) Cases attending physician was deemed inappropriate

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Complete Response grade0 rate of creatinin
Secondary Outcome Measures
NameTimeMethod
Completion rate, Complete Control rate, adverse events, total control rate
© Copyright 2025. All Rights Reserved by MedPath